vs
FIRST ADVANTAGE CORP（FA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是FIRST ADVANTAGE CORP的1.5倍（$622.0M vs $420.0M），Royalty Pharma plc净利率更高（34.4% vs 0.8%，领先33.6%），FIRST ADVANTAGE CORP同比增速更快（36.8% vs 4.8%），过去两年FIRST ADVANTAGE CORP的营收复合增速更高（57.5% vs 4.6%）
First Advantage是全球领先的劳动力筛查与背景验证服务提供商，服务覆盖科技、医疗、金融、零售、制造等多个行业的各规模客户，助力企业管控雇佣风险、满足合规要求，打造安全可信的工作环境。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FA vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.5倍
$420.0M
营收增速更快
FA
高出32.0%
4.8%
净利率更高
RPRX
高出33.6%
0.8%
两年增速更快
FA
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $420.0M | $622.0M |
| 净利润 | $3.5M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 10.7% | 62.4% |
| 净利率 | 0.8% | 34.4% |
| 营收同比 | 36.8% | 4.8% |
| 净利润同比 | 103.5% | 2.9% |
| 每股收益（稀释后） | $0.03 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FARPRX
| Q4 25 | $420.0M | $622.0M | ||
| Q3 25 | $409.2M | $609.3M | ||
| Q2 25 | $390.6M | $578.7M | ||
| Q1 25 | $354.6M | $568.2M | ||
| Q4 24 | $307.1M | $593.6M | ||
| Q3 24 | $199.1M | $564.7M | ||
| Q2 24 | $184.5M | $537.3M | ||
| Q1 24 | $169.4M | $568.0M |
净利润FARPRX
| Q4 25 | $3.5M | $214.2M | ||
| Q3 25 | $2.6M | $288.2M | ||
| Q2 25 | $308.0K | $30.2M | ||
| Q1 25 | $-41.2M | $238.3M | ||
| Q4 24 | $-100.4M | $208.2M | ||
| Q3 24 | $-8.9M | $544.0M | ||
| Q2 24 | $1.9M | $102.0M | ||
| Q1 24 | $-2.9M | $4.8M |
营业利润率FARPRX
| Q4 25 | 10.7% | 62.4% | ||
| Q3 25 | 10.3% | 70.1% | ||
| Q2 25 | 9.7% | 36.3% | ||
| Q1 25 | 2.1% | 94.0% | ||
| Q4 24 | -26.3% | 60.9% | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 5.4% | 50.2% | ||
| Q1 24 | -0.4% | -13.0% |
净利率FARPRX
| Q4 25 | 0.8% | 34.4% | ||
| Q3 25 | 0.6% | 47.3% | ||
| Q2 25 | 0.1% | 5.2% | ||
| Q1 25 | -11.6% | 41.9% | ||
| Q4 24 | -32.7% | 35.1% | ||
| Q3 24 | -4.4% | 96.3% | ||
| Q2 24 | 1.0% | 19.0% | ||
| Q1 24 | -1.7% | 0.8% |
每股收益（稀释后）FARPRX
| Q4 25 | $0.03 | $0.49 | ||
| Q3 25 | $0.01 | $0.67 | ||
| Q2 25 | $0.00 | $0.07 | ||
| Q1 25 | $-0.24 | $0.55 | ||
| Q4 24 | $-0.67 | $0.46 | ||
| Q3 24 | $-0.06 | $1.21 | ||
| Q2 24 | $0.01 | $0.23 | ||
| Q1 24 | $-0.02 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $240.0M | $618.7M |
| 总债务越低越好 | $2.1B | $9.0B |
| 股东权益账面价值 | $1.3B | $9.7B |
| 总资产 | $3.8B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.61× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FARPRX
| Q4 25 | $240.0M | $618.7M | ||
| Q3 25 | $216.8M | $938.9M | ||
| Q2 25 | $184.3M | $631.9M | ||
| Q1 25 | $172.0M | $1.1B | ||
| Q4 24 | $168.7M | $929.0M | ||
| Q3 24 | $307.4M | $950.1M | ||
| Q2 24 | $269.6M | $1.8B | ||
| Q1 24 | $246.0M | $843.0M |
总债务FARPRX
| Q4 25 | $2.1B | $9.0B | ||
| Q3 25 | $2.1B | $8.9B | ||
| Q2 25 | $2.1B | $8.0B | ||
| Q1 25 | $2.2B | $7.6B | ||
| Q4 24 | $2.2B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益FARPRX
| Q4 25 | $1.3B | $9.7B | ||
| Q3 25 | $1.3B | $9.6B | ||
| Q2 25 | $1.3B | $9.5B | ||
| Q1 25 | $1.3B | $9.8B | ||
| Q4 24 | $1.3B | $10.3B | ||
| Q3 24 | $920.7M | $10.3B | ||
| Q2 24 | $913.3M | $9.8B | ||
| Q1 24 | $907.7M | $9.9B |
总资产FARPRX
| Q4 25 | $3.8B | $19.6B | ||
| Q3 25 | $3.9B | $19.3B | ||
| Q2 25 | $3.9B | $18.3B | ||
| Q1 25 | $3.9B | $17.6B | ||
| Q4 24 | $3.9B | $18.2B | ||
| Q3 24 | $1.7B | $18.0B | ||
| Q2 24 | $1.6B | $17.7B | ||
| Q1 24 | $1.6B | $16.1B |
负债/权益比FARPRX
| Q4 25 | 1.61× | 0.92× | ||
| Q3 25 | 1.64× | 0.93× | ||
| Q2 25 | 1.65× | 0.84× | ||
| Q1 25 | 1.69× | 0.78× | ||
| Q4 24 | 1.66× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $65.9M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $62.2M | — |
| 自由现金流率自由现金流/营收 | 14.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 19.01× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $188.5M | — |
8季度趋势，按日历期对齐
经营现金流FARPRX
| Q4 25 | $65.9M | $827.1M | ||
| Q3 25 | $72.4M | $702.6M | ||
| Q2 25 | $37.3M | $364.0M | ||
| Q1 25 | $19.5M | $596.1M | ||
| Q4 24 | $-85.7M | $742.5M | ||
| Q3 24 | $43.5M | $703.6M | ||
| Q2 24 | $32.0M | $658.2M | ||
| Q1 24 | $38.3M | $664.6M |
自由现金流FARPRX
| Q4 25 | $62.2M | — | ||
| Q3 25 | $71.2M | — | ||
| Q2 25 | $36.1M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $-86.0M | — | ||
| Q3 24 | $43.1M | — | ||
| Q2 24 | $31.4M | — | ||
| Q1 24 | $38.0M | — |
自由现金流率FARPRX
| Q4 25 | 14.8% | — | ||
| Q3 25 | 17.4% | — | ||
| Q2 25 | 9.2% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | -28.0% | — | ||
| Q3 24 | 21.6% | — | ||
| Q2 24 | 17.0% | — | ||
| Q1 24 | 22.4% | — |
资本支出强度FARPRX
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.2% | — |
现金转化率FARPRX
| Q4 25 | 19.01× | 3.86× | ||
| Q3 25 | 27.91× | 2.44× | ||
| Q2 25 | 121.25× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 17.22× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FA
| First Advantage Americas | $209.9M | 50% |
| Sterling | $185.9M | 44% |
| First Advantage International | $24.2M | 6% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
